InMed Pharmaceuticals announces increase in Bought Deal offering to $13 million
InMed Pharmaceuticals Inc. (TSX:IN) is pleased to announce that it has entered into an amended letter of engagement with Eight Capital, under which Eight Capital has now agreed to purchase, as underwriter, 14,444,560 units of the Company, on a “bought deal” basis pursuant to the filing of a shelf prospectus... Read more
Medical Cannabis Leadership from Canopy Growth and Subsidiary Spectrum Cannabis
Canopy Growth Corporation (TSX: WEED) (NYSE: CGC) is pleased to provide the following updates on its medical cannabis program and to re-affirm its strong commitment to medical cannabis, the patients who depend on it, and the Healthcare Professionals who prescribe it. HISTORIC CLINICAL TRIAL MILESTONES Marking a major milestone for medical... Read more
Aurora Cannabis to Acquire Cannabis Science Leader Anandia Laboratories Inc.
Aurora Cannabis Inc. (TSX: ACB) (OTCQB: ACBFF) (Frankfurt: 21P; WKN: A1C4WM) and Anandia Laboratories Inc.  announced today that they have signed a binding term sheet whereby Aurora intends to acquire all of the issued and outstanding common shares of privately-held Anandia in an all share transaction valued at approximately $115 million on... Read more
TerrAscend and Cistron Launch Ascendant Laboratories
TerrAscend Corp. (CSE: TER) is pleased to announce the formation of a strategic joint venture with Cistron Corp. with the launch of Ascendant Laboratories Inc., a science and innovation company dedicated to the advancement of cannabinoid expressing plant biology. Ascendant Laboratories brings together leaders in plant sciences and cannabis... Read more
Aphria to build state-of-the art Extraction Centre of Excellence
Aphria Inc. (TSX: APH and US OTC: APHQF) today announced that the company’s Board of Directors approved a $55 million capital project to build a state-of-the-art Extraction Centre of Excellence in Leamington, ON. The facility will be equipped to conduct a wide range of cannabis extractions, including C02, butane and ethanol, and produce... Read more
MedMen Announces Acquisition of Florida Marijuana License and Cultivation Facility
MedMen Enterprises Inc. (CSE: MMEN), the country’s leading cultivator, producer and retailer of state-sanctioned cannabis, today announced that it has signed a definitive agreement to acquire dispensary and cultivation assets from Florida based Treadwell Simpson Partnership and affiliates. As part of the transaction, MedMen will acquire Treadwell Nursery’s cultivation facility... Read more
( ) ( ) ( ) ( ) ( ) ( ) ( ) ( )